bruce@senovatech.com
Hello,I am Bruce from China.Can I connect to take this forward?
marketing@baschamlifesciences.com
Greetings from Bascham Life Sciences
We are pleased to inform you that we can support this requirement. Kindly share your contact details on our email to proceed further
Regards
Bascham Team, India
archana@pharmalinksindia.com
Dear Sir/Madam,
We would be interested to cater to your needs and take this ahead. Pls share more details about you or email us on archana@pharmalinksindia.com
Rgds
Archana B
+91 8657527957
Please send us email to communicate with you .
hostrinlifesciences@gmail.com
Dear Friend,
Greetings from Hostrin Life sciences!!!
We have been supporting for the following services.
1.We do support DMF's for API's, Tech transfer support and Registration of Dossiers in MOH /MHRA/EMEA/USA support in CTD, ACTD, eCTD and ANDA's formats with 5 modules including BA and BE studies /Clinical studies/trials for API's & Formulation's in Pharmaceutical, Ayurveda, Biotech, Biosimilar, vitamins , Peptides and recently Transdermal patches too.
2. Impurity's & Reference standards support for API's
3. Services for IPR & Regulatory compliance
4. Services for QMS & supporting of QBD - SIGMA TECH Software version 3.1 for DOE, Robustness for the R&D in Pharma, Biotech, Biosimilars companies who are willing to enter into the Regulatory market which is mandatory to show for FDA.
5. Custom synthesis & Contract manufacturing services
6. Synthetic Resins technologies support
Pls don't hesitate to send your enquiry's. For your reference please go through our website www.hostringlobal.com
Best Regards,
Andrew P
CEO & Managing Director
Hostrin Life sciences
hostrinlifesciences@gmail.com
andrew@hostringlobal.com
Mobile/
WhatsApp: +91 9949930343
hostrinlifesciences@gmail.com
Dear Friend,
Greetings from Hostrin Life sciences!!!
We have been supporting for the following services.
1.We do support DMF's for API's, Tech transfer support and Registration of Dossiers in MOH /MHRA/EMEA/USA support in CTD, ACTD, eCTD and ANDA's formats with 5 modules including BA and BE studies /Clinical studies/trials for API's & Formulation's in Pharmaceutical, Ayurveda, Biotech, Biosimilar, vitamins , Peptides and recently Transdermal patches too.
2. Impurity's & Reference standards support for API's
3. Services for IPR & Regulatory compliance
4. Services for QMS & supporting of QBD - SIGMA TECH Software version 3.1 for DOE, Robustness for the R&D in Pharma, Biotech, Biosimilars companies who are willing to enter into the Regulatory market which is mandatory to show for FDA.
5. Custom synthesis & Contract manufacturing services
6. Synthetic Resins technologies support
Pls don't hesitate to send your enquiry's. For your reference please go through our website www.hostringlobal.com
Best Regards,
Andrew P
CEO & Managing Director
Hostrin Life sciences
hostrinlifesciences@gmail.com
andrew@hostringlobal.com
Mobile/
WhatsApp: +91 9949930343
info@aeqpharma.com
Dear Sir,
My staurtup company can supply biosimilars API, CHO cell lines.
We have trading division for API and high potency & Cytotoxics API portfolio as following :
Droxidopa,
Gemcitabine
Cisplatin
Carboplatin
Oxaliplatin
Dacarbazine
Thiotepa
Bendamustin
Paclitaxel
Docetaxel
The paclitaxel we produce ishighly pure(>97%), compliant toUSP, Eur.Ph. and Japanese Ph.
Isopropyl-beta-D-thiogalactopyranoside?IPTG?,CAS NO:367-93-1
10-Deacetylbaccatin III, CAS NO: 32981-86-5
7-Deoxy-10-Deacetylbaccatin III ?CAS 173442-30-
Intermediaries:
1. 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole(CAS No.152628-02-9)
2. 4’-Bromomethyl-2-cyanobiphenyl(CAS No.114772-54-2)-
3. Glimepiride Sulfonamide (CAS No.119018-29-0)-
Enoxaparin,Heparinoids,
Stable isotopes,18F, 11C, 68Ga , 18F-labeled compounds (18FCH, 18FLT, Na18F),MO99, Water-18 O isotopes.
PET&SPECT Precursors
PET Chemicals Application: Precursor for radiolabelled DOTA-[Tyr3]octreotate
Ruxolinitib
Fluticasone Propionate
Salmeterol Xinafoate
Salbutamol
Formoterol Fumarate Dihydrate
Aclidinium
Umeclidinium
sales@gpbiopharm.com
Pls contact with Ms. Vivia from M/s Jiaxing GP Biopharm, which is ruxolitinib manufacturer.